NawlHeata
09-03-2022, 05:04 AM
The odds ratios were significant for all clinical populations examined, including age, smoking, alcohol use, and baseline BMI, diabetes, cardiovascular disorder, hypertension, and hyperlipidemia, and the results were fairly consistent across all doses and regimens, with the exception of the low-dose OAD regimen in the clinical populations younger than 50 and at least 65 years old, with baseline BMI of at least 30 kg m 2 , with diabetes mellitus, with no cardiovascular disorder, and those who smoked is stromectol the same as ivermectin ([Only registered and activated users can see links])